Free Newsletter
HIV vax trial recruiters get edgy with social media strategies
One of the hottest trends in clinical trial development these days is the use of social media to recruit suitable subjects, and that hasn't gone unnoticed in HIV vaccine research circles.
The HIV Vaccine Trials Network, which is headquartered at the renowned Fred Hutchinson Cancer Research Center in Seattle, has turned to ads on Facebook to find 1,350 HIV-negative gay men for a new study. They're taking a distinctly more provocative approach on online gay ‘hook-up sites.' And some recruiters are scouring the personal ads online to find subjects.
In some cases, champions of the vaccine trials are starting their own Facebook groups. Edward Todd, for example, helped engage the attention of 1,200 gay men online, and at least six are already enrolled.
- here's the press release for more info
Related Articles:
Promoting your biotech through social media
AIDS vax a surprising success in big trial
World AIDS day marked by new vaccine progress
Social media still uncharted for pharma
Comments
Does using social media for the trial purpose is ethical?
The media had always put a dark side of the trials that indirectly scripted a wrong views to a common person. The most important thing which I feel as per GCP guidelines is violating by using the social networking for the trial related purpose is "confidentiality of the subjects recruiting in the trial". The social networking should be used for limited purpose only.
Post new comment
Paid Research Reports
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Pharmaceutical Licensing Overview
- Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina
- Pharmaceutical Key Trends 2010
- Commercial Insight: Top 20 Oncology Therapy Brands in Australia
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
SHARE
WITH: